Document Detail


Baby's Breath II protocol development and design: a secondhand smoke exposure prevention program targeting infants discharged from a neonatal intensive care unit.
MedLine Citation:
PMID:  23466754     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Over one-third of all children live with at least one parent who smokes cigarettes, which is associated with compromised child health. The impact of secondhand smoke exposure (SHSe) in medically fragile infants born prematurely is likely to be much higher. The Baby's Breath II study tests whether a hospital-initiated, motivational-enhancement program will result in less SHSe relative to conventional care in high-risk, low birthweight (LBW) infants discharged from a neonatal intensive care unit (NICU). The design and protocol for the ongoing BBII trial is described.
METHODS/DESIGN: Eligible participants are: (1) primary caregivers (typically mothers) of NICU infants who were born at LBW (<2500g) or ventilated for more than 12h; and (2) who smoke or live with at least one smoker. This randomized controlled trial has two conditions: Motivational interviewing plus incentives (MI+) and conventional care (CC). MI+ participants receive two hospital-based and two home-based counseling sessions, as well as incentives (i.e., prize-based draws) for (a) intervention attendance and (b) biochemical validation (i.e., urine cotinine dipstick) indicative of low or no infant SHSe. Participants in the control group receive conventional education-based care. Assessments are completed at baseline, mid-point, and 1- and 4-months post-intervention.
DISCUSSION: This study is the first to determine the efficacy of a brief intervention for reducing SHSe among high-risk, LBW infants discharged from a NICU, with the potential for saving lives and healthcare costs. Strengths, limitations and challenges to the conduct of this trial are discussed.
Authors:
Angela L Stotts; Thomas F Northrup; Joy M Schmitz; Charles Green; Jon Tyson; Mary M Velasquez; Amir Khan; Melbourne F Hovell
Related Documents :
8301424 - Incidence of sudden infant death syndrome in infants with sickle cell trait.
11408104 - International child care practices study: infant sleep position and parental smoking.
582364 - Extramedullary hematopoiesis in the liver in sudden infant death syndrome.
16582034 - Recent national trends in sudden, unexpected infant deaths: more evidence supporting a ...
23651394 - Early diet impacts infant rhesus gut microbiome, immunity and metabolism.
7514784 - Post extracorporeal membrane oxygenation single photon emission computed tomography (sp...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2013-03-01
Journal Detail:
Title:  Contemporary clinical trials     Volume:  35     ISSN:  1559-2030     ISO Abbreviation:  Contemp Clin Trials     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-29     Completed Date:  2013-12-17     Revised Date:  2014-05-07    
Medline Journal Info:
Nlm Unique ID:  101242342     Medline TA:  Contemp Clin Trials     Country:  United States    
Other Details:
Languages:  eng     Pagination:  97-105     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Caregivers
Counseling / education
Humans
Infant, Low Birth Weight*
Infant, Newborn
Inhalation Exposure
Intensive Care Units, Neonatal
Motivational Interviewing
Patient Discharge
Tobacco Smoke Pollution / prevention & control*
Grant Support
ID/Acronym/Agency:
R01 HL107404/HL/NHLBI NIH HHS; R01 HL107404/HL/NHLBI NIH HHS; UL1 TR000371/TR/NCATS NIH HHS
Chemical
Reg. No./Substance:
0/Tobacco Smoke Pollution
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer.
Next Document:  mRNA fate: Life and death of the mRNA in the cytoplasm.